Dublin, Ohio-based Cardinal Health, Inc. (CAH) manufactures and distributes pharmaceuticals, medical & laboratory products, ...

The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...

Cardinal Health warned Thursday that if President Donald Trump follows through with threatened tariffs next month, higher ...

Jefferies has upgraded Cardinal Health (CAH) to buy from hold, citing management's emerging EPS track record. Read more here.

Healthcare distributor and services company Cardinal Health (NYSE:CAH) in Q4 CY2024, but sales fell by 3.8% year on year to ...

Headquartered in Columbus, Ohio, Cardinal Health is a global, integrated healthcare services and products company that generated $205 billion in revenue in its fiscal year 2023. The company plays ...

Cardinal Health reported an increase in revenue for two of its segments, while the departure of Optimum impacted its ...

Cardinal Health CEO Jason Hollar recounted the company's "nice run" at the nation's largest annual healthcare industry conference. Cardinal Health Inc. raised its earnings outlook for fiscal 2025 ...

Drug distributor Cardinal Health said on Thursday it may need to increase prices of some of its products if the proposed tariffs on Mexico go into effect, to counter increasing costs of manufacturing ...

Argus analyst Kristina Ruggeri raised the firm’s price target on Cardinal Health (CAH) to $148 from $145 and keeps a Buy rating on the shares.

Cardinal's forecast came ahead of a presentation at the JPMorgan Healthcare Conference, where the company is expected to provide more comments. Sign up here. All three U.S. stock indexes closed ...

Morgan Stanley analyst Erin Wright maintained a Buy rating on Cardinal Health (CAH – Research Report) today and set a price target of $136.00. The company’s shares closed yesterday at $130.73. Wright ...